PRESENTATION |
PRESENTERS |
AFFILIATION |
Chair Welcome |
Funda Meric-Bernstam, MD |
MD Anderson Cancer Center |
Cholangiocarcinoma Foundation Welcome, Mark R. Clements Awards Ceremony, Fellowship Program |
Stacie Lindsey |
Cholangiocarcinoma Foundation |
International Cholangiocarcinoma Research Network (ICRN) Updates |
Mitesh Borad, MD |
Mayo Clinic |
Session I: Updates on Genomically Informed Therapy in CCA
Moderators: Laura Goff, MD Vanderbilt University
Chiara Braconi, MD University of Glasgow, Scotland |
Novel Genomic Opportunities- BAP1, CDK, ARID1A |
Sarinya Kongpetch, PhD |
Khon Kaen University, Thailand |
Targeting HER2 in Biliary Tract Cancers |
Shubham Pant, MD |
MD Anderson Cancer Center |
DNA Damage Repair |
Timothy Yap, MBBS, PhD, FRCP |
MD Anderson Cancer Center |
MAPK Pathway Targeting in Cholangiocarcinoma |
Ardaman Shergill, MD, MSPH |
University of Chicago |
Updates on Genomically Formed Therapy in CCA - IDH1/IDH2 |
Mitesh Borad, MD |
Mayo Clinic |
FGFR |
Ghassan Abou-Alfa, MD, MBA |
MSKCC |
Panel Discussion |
All |
|
My Journey with Cholangiocarcinoma & How Raising Awareness Keeps Me Going |
Jan Meyer |
|
Session IIA: Management of Bile Duct Occlusion and Session IIB: Patient Led Data Initiatives
Moderator: John Bridgewater, MRCP PhD FRCP, University College London, UK |
Management of Urgent Symptoms in Cholangiocarcinoma Patients with Biliary Stents/Drains: Delphi Panel Guidelines |
Juan Valle, MD |
University of Manchester, UK |
Biliary Emergency Care: Real World Data |
Renuka Iyer, MD |
Roswell Park Cancer Center |
Natural Course, Management and Outcome of Patients with Cholangiocarcinoma in European Countries: An ENS-CCA Registry Study |
Jesus Banales, PhD |
Biodonostia Health Research Institute, Spain |
Panel Discussion |
All |
|
Poster Session: Rapid Oral Abstracts & Awards |
Moderators: Funda Meric-Bernstam, MD & Jesper B. Andersen, MSc, PhD |
Placental growth factor promotes tumor desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma |
Shuichi Aoki |
Tohoku Graduate School of Medicine, Japan |
Modulating cholangiocarcinoma's tumor microenvironment enhances response to immune checkpoint blockade |
Laurence Diggs |
National Cancer Institute |
Futibatinib in patients with intrahepatic cholangiocarcinoma (iCCA) harboring FGFR2 fusions/rearrangements: FOENIX-CCA2 |
Lipika Goyal |
Harvard Medical School |
Longitudinal monitoring of actionable somatic alterations in advanced cholangiocarcinoma from circulating tumor DNA profiling |
Pashtoon Kasi |
University of Iowa |
Oncologic quality metrics for biliary tract cancer surgery – differential performance by approach |
Bradford Kim |
The University of Texas MD Anderson Cancer Center |
Time to rethink upfront surgery for resectable intrahepatic cholangiocarcinoma? Implications from the neoadjuvant experience |
Meredith Mason |
The University of Texas MD Anderson Cancer Center |
Results from the Ph 1 study of Zanidatamab in HER2-expressing biliary tract cancers & design of HERIZON-BTC-01 (Ph 2) study |
Shubham Pant |
The University of Texas MD Anderson Cancer Center |
Potential resistance mechanisms to FGFR inhibitors (FGFRi) in FGFR2 rearranged (FGFR2 RE+) cholangiocarcinoma |
Ahmed S Shalaby |
The University of Texas MD Anderson Cancer Center |
Caregiver Perspective from a Father |
Chris Cochran |
|
Session III: Locoregional Management of Cholangiocarcinoma
Moderators: Ching-Wei Tzeng, MD, FACS - MD Anderson Cancer Center
Shishir Maithel, MD - Emory University |
Liver Transplantation for Intrahepatic Cholangiocarcinoma |
R. Mark Ghobrial, MD |
Houston Methodist Hospital |
Hepatic Artery Infusion Pump for Treatment of Intrahepatic Cholangiocarcinoma |
Chet Hammill, MD, MCR, FACS |
Washington University in St. Louis |
Surgical Management of Intrahepatic Cholangiocarcinoma |
Timothy Pawlik, MD, MPH, PhD |
Ohio State University Wexner Medical Center |
Ablation & Chemoembolization (TACE) |
Bruno Odisio, MD |
MD Anderson Cancer Center |
SIRT for ICC |
Julien Edeline, MD |
Centre Eugene Marquis, France |
Radiation Therapy |
Maria Hawkins, MD, MCRP, FRCR |
University College London, UK |
Panel Discussion |
All |
|
Closing |
Stacie Lindsey |
Cholangiocarcinoma Foundation |